O	O	0	6	Immune	Immune	B-NP	JJ	O	2	NMOD	O
O	O	7	22	hyperactivation	hyperactivation	I-NP	NN	O	0	ROOT	O
O	O	23	25	of	of	B-PP	IN	O	2	NMOD	O
O	O	26	29	HIV	HIV	B-NP	NN	B-cell_type	10	NMOD	B-cell_type
O	O	29	30	-	-	B-NP	HYPH	I-cell_type	10	NMOD	I-cell_type
O	O	30	31	1	1	I-NP	CD	I-cell_type	10	NMOD	I-cell_type
O	O	31	32	-	-	I-NP	HYPH	I-cell_type	10	NMOD	I-cell_type
O	O	32	40	infected	infect	I-NP	VBN	I-cell_type	10	NMOD	I-cell_type
O	O	41	42	T	T	I-NP	NN	I-cell_type	10	NMOD	I-cell_type
O	O	43	48	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	49	57	mediated	mediate	B-VP	VBN	O	10	NMOD	O
O	O	58	60	by	by	B-PP	IN	O	11	VMOD	O
O	O	61	64	Tat	Tat	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	65	68	and	and	O	CC	O	17	NMOD	O
O	O	69	72	the	the	B-NP	DT	O	17	NMOD	O
T1	B-Protein	73	77	CD28	CD28	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	78	85	pathway	pathway	I-NP	NN	O	12	PMOD	O
O	O	85	86	.	.	O	.	O	2	P	O

O	O	88	93	Human	Human	B-NP	JJ	O	3	NMOD	O
O	O	94	110	immunodeficiency	immunodeficiency	I-NP	NN	O	3	NMOD	O
O	O	111	116	virus	virus	I-NP	NN	O	12	NMOD	O
O	O	116	117	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	117	121	type	type	I-NP	NN	O	12	NMOD	O
O	O	122	123	1	1	I-NP	CD	O	5	NMOD	O
O	O	124	125	(	(	O	(	O	11	DEP	O
O	O	125	128	HIV	HIV	B-NP	NN	O	10	SUB	O
O	O	128	129	-	-	B-NP	HYPH	O	10	P	O
O	O	129	130	1	1	I-NP	CD	O	11	DEP	O
O	O	130	131	)	)	O	)	O	5	NMOD	O
O	O	132	141	infection	infection	B-NP	NN	O	13	SUB	O
O	O	142	144	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	145	158	characterized	characterize	I-VP	VBN	O	13	VC	O
O	O	159	161	by	by	B-PP	IN	O	14	VMOD	O
O	O	162	163	a	a	B-NP	DT	O	18	NMOD	O
O	O	164	171	chronic	chronic	I-NP	JJ	O	18	NMOD	O
O	O	172	177	state	state	I-NP	NN	O	15	PMOD	O
O	O	178	180	of	of	B-PP	IN	O	18	NMOD	O
O	O	181	187	immune	immune	B-NP	JJ	O	21	NMOD	O
O	O	188	203	hyperactivation	hyperactivation	I-NP	NN	O	19	PMOD	O
O	O	204	206	in	in	B-PP	IN	O	18	NMOD	O
O	O	207	215	patients	patient	B-NP	NNS	O	22	PMOD	O
O	O	215	216	.	.	O	.	O	13	P	O

O	O	217	226	Infection	Infection	B-NP	NN	O	13	SUB	O
O	O	227	229	of	of	B-PP	IN	O	1	NMOD	O
O	O	230	235	human	human	B-NP	JJ	B-cell_type	6	NMOD	B-cell_type
O	O	236	246	peripheral	peripheral	I-NP	JJ	I-cell_type	6	NMOD	I-cell_type
O	O	247	252	blood	blood	I-NP	NN	I-cell_type	6	NMOD	I-cell_type
O	O	253	264	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	265	269	with	with	B-PP	IN	O	1	NMOD	O
O	O	270	273	HIV	HIV	B-NP	NN	O	7	PMOD	O
O	O	273	274	-	-	B-NP	HYPH	O	8	P	O
O	O	274	275	1	1	I-NP	CD	O	8	NMOD	O
O	O	276	278	in	in	B-ADVP	FW	O	1	NMOD	O
O	O	279	284	vitro	vitro	I-ADVP	FW	O	11	AMOD	O
O	O	285	293	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	294	296	in	in	B-PP	IN	O	13	VMOD	O
O	O	297	306	increased	increase	B-NP	VBN	O	18	NMOD	O
T2	B-Protein	307	318	interleukin	interleukin	I-NP	NN	B-protein	18	NMOD	B-protein
T2	I-Protein	318	319	-	-	O	HYPH	O	18	P	O
T2	I-Protein	319	320	2	2	B-NP	CD	O	24	NMOD	O
O	O	321	322	(	(	O	(	O	23	DEP	O
T3	B-Protein	322	324	IL	IL	B-NP	NN	B-protein	23	DEP	B-protein
T3	I-Protein	324	325	-	-	O	HYPH	I-protein	20	NMOD	I-protein
T3	I-Protein	325	326	2	2	O	CD	I-protein	20	NMOD	I-protein
O	O	326	327	)	)	O	)	O	18	NMOD	O
O	O	328	337	secretion	secretion	B-NP	NN	O	14	PMOD	O
O	O	338	340	in	in	B-PP	IN	O	24	NMOD	O
O	O	341	349	response	response	B-NP	NN	O	25	PMOD	O
O	O	350	352	to	to	B-PP	TO	O	26	NMOD	O
O	O	353	354	T	T	B-NP	NN	O	30	NMOD	O
O	O	355	359	cell	cell	I-NP	NN	O	30	NMOD	O
O	O	360	370	activation	activation	I-NP	NN	O	27	PMOD	O
O	O	371	374	via	via	B-PP	IN	O	30	NMOD	O
O	O	375	378	the	the	B-NP	DT	O	36	NMOD	O
O	O	379	382	CD3	CD3	I-NP	NN	B-protein	36	NMOD	B-protein
O	O	383	386	and	and	I-NP	CC	I-protein	36	NMOD	I-protein
O	O	387	391	CD28	CD28	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	392	401	receptors	receptor	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	401	402	.	.	O	.	O	13	P	O

O	O	403	413	Expression	Expression	B-NP	NN	O	9	SUB	O
O	O	414	416	of	of	B-PP	IN	O	1	NMOD	O
O	O	417	420	the	the	B-NP	DT	O	8	NMOD	O
O	O	421	424	HIV	HIV	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	424	425	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
O	O	425	426	1	1	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	427	441	transactivator	transactivator	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	442	445	Tat	Tat	I-NP	NN	B-protein	2	PMOD	B-protein
O	O	446	459	recapitulated	recapitulate	B-VP	VBD	O	0	ROOT	O
O	O	460	464	this	this	B-NP	DT	O	11	NMOD	O
O	O	465	474	phenotype	phenotype	I-NP	NN	O	9	OBJ	O
O	O	475	478	and	and	O	CC	O	9	VMOD	O
O	O	479	482	was	be	B-VP	VBD	O	9	VMOD	O
O	O	483	493	associated	associate	I-VP	VBN	O	13	VC	O
O	O	494	498	with	with	B-PP	IN	O	14	VMOD	O
O	O	499	508	increased	increase	B-NP	VBN	O	20	NMOD	O
T4	B-Protein	509	511	IL	IL	I-NP	NN	B-protein	20	NMOD	B-protein
T4	I-Protein	511	512	-	-	I-NP	HYPH	I-protein	20	NMOD	I-protein
T4	I-Protein	512	513	2	2	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	514	523	secretion	secretion	I-NP	NN	O	15	PMOD	O
O	O	524	526	in	in	B-PP	IN	O	20	NMOD	O
O	O	527	535	response	response	I-PP	NN	O	21	PMOD	O
O	O	536	538	to	to	I-PP	TO	O	22	NMOD	O
O	O	539	552	costimulation	costimulation	B-NP	NN	O	23	PMOD	O
O	O	553	557	with	with	B-PP	IN	O	24	NMOD	O
T9	B-Entity	558	561	CD3	CD3	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	562	566	plus	plus	I-NP	CC	O	28	NMOD	O
T5	B-Protein	567	571	CD28	CD28	I-NP	NN	B-protein	25	PMOD	B-protein
O	O	571	572	.	.	O	.	O	9	P	O

T6	B-Protein	573	575	IL	IL	B-NP	NN	B-protein	7	SUB	B-protein
T6	I-Protein	575	576	-	-	I-NP	HYPH	I-protein	1	NMOD	I-protein
T6	I-Protein	576	577	2	2	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	578	592	superinduction	superinduction	I-NP	NN	O	1	NMOD	O
O	O	593	595	by	by	B-PP	IN	O	1	NMOD	O
O	O	596	599	Tat	Tat	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	600	608	occurred	occur	B-VP	VBD	O	0	ROOT	O
O	O	609	611	at	at	B-PP	IN	O	7	VMOD	O
O	O	612	615	the	the	B-NP	DT	O	11	NMOD	O
O	O	616	631	transcriptional	transcriptional	I-NP	JJ	O	11	NMOD	O
O	O	632	637	level	level	I-NP	NN	O	8	PMOD	O
O	O	637	638	,	,	O	,	O	7	P	O
O	O	639	642	was	be	B-VP	VBD	O	7	VMOD	O
O	O	643	651	mediated	mediate	I-VP	VBN	O	13	VC	O
O	O	652	654	by	by	B-PP	IN	O	14	VMOD	O
O	O	655	658	the	the	B-NP	DT	O	20	NMOD	O
T7	B-Protein	659	663	CD28	CD28	I-NP	NN	B-protein	20	NMOD	B-protein
T10	B-Entity	663	664	-	-	B-NP	HYPH	O	20	NMOD	O
T10	I-Entity	664	674	responsive	responsive	I-NP	JJ	B-DNA	20	NMOD	B-DNA
T10	I-Entity	675	682	element	element	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	683	685	in	in	B-PP	IN	O	20	NMOD	O
O	O	686	689	the	the	B-NP	DT	O	26	NMOD	O
T8	B-Protein	690	692	IL	IL	I-NP	NN	B-DNA	26	NMOD	B-DNA
T8	I-Protein	692	693	-	-	I-NP	HYPH	I-DNA	26	NMOD	I-DNA
T8	I-Protein	693	694	2	2	I-NP	CD	I-DNA	26	NMOD	I-DNA
T11	B-Entity	695	703	promoter	promoter	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	703	704	,	,	O	,	O	7	P	O
O	O	705	708	and	and	O	CC	O	7	VMOD	O
O	O	709	712	was	be	B-VP	VBD	O	7	VMOD	O
O	O	713	724	exclusively	exclusively	B-ADJP	RB	O	31	AMOD	O
O	O	725	734	dependent	dependent	I-ADJP	JJ	O	29	PRD	O
O	O	735	737	on	on	B-PP	IN	O	31	AMOD	O
O	O	738	741	the	the	B-NP	DT	O	36	NMOD	O
T12	B-Entity	742	744	29	29	I-NP	CD	B-protein	36	NMOD	B-protein
T12	I-Entity	745	750	amino	amino	I-NP	NN	I-protein	36	NMOD	I-protein
T12	I-Entity	751	756	acids	acid	I-NP	NNS	I-protein	32	PMOD	I-protein
T12	I-Entity	757	764	encoded	encode	B-VP	VBN	O	36	NMOD	O
T12	I-Entity	765	767	by	by	B-PP	IN	O	37	VMOD	O
T12	I-Entity	768	771	the	the	B-NP	DT	O	41	NMOD	O
T12	I-Entity	772	778	second	second	I-NP	JJ	O	41	NMOD	O
T12	I-Entity	779	783	exon	exon	I-NP	NN	B-DNA	38	PMOD	B-DNA
T12	I-Entity	784	786	of	of	B-PP	IN	O	41	NMOD	O
T12	I-Entity	787	790	Tat	Tat	B-NP	NN	B-protein	42	PMOD	B-protein
O	O	790	791	.	.	O	.	O	7	P	O
